In a filing, Enliven Therapeutics Inc revealed its CHIEF FINANCIAL OFFICER Hohl Benjamin unloaded Company’s shares for reported $66504.0 on
In a filing, Enliven Therapeutics Inc revealed its Officer Hohl Benjamin acquired Company’s shares for reported $90100.0 on Jul 28
In a filing, Enliven Therapeutics Inc revealed its PRESIDENT AND CEO Kintz Samuel unloaded Company’s shares for reported $0.28 million
In a filing, Enliven Therapeutics Inc revealed its CHIEF FINANCIAL OFFICER Hohl Benjamin unloaded Company’s shares for reported $22655.0 on
Enliven Therapeutics Inc’s recent filing unveils that its CHIEF FINANCIAL OFFICER Hohl Benjamin unloaded Company’s shares for reported $67956.0 on
Enliven Therapeutics Inc’s recently made public that its CHIEF SCIENTIFIC OFFICER Lyssikatos Joseph P unloaded Company’s shares for reported $0.27